Ra Capital Management, L.p.

Filing Details

13F-HR • 2025-03-31

SEC FilingSEC DataHachi Filing

Report Date: 2025-03-31
Filing Date: 2025-05-15
Total Holdings: 85
Total Value: 5952606666
Accession Number: 0001104659-25-049549
Form Type: 13F-HR
CIK: 0001346824
Manager Name: Ra Capital Management, L.p.

Data Enrichment

91% identified

77 identified8 unidentified

Holdings

SEC FilingSEC DataHachi Filing

Manager:

85 positions • $5,952,606.666K total value

85 positions

Manager:

SEC FilingSEC DataHachi Filing

Search and click to pin securities to the top

Page 3 of 5

Sort by:

Nkarta, Inc.

NKTX|65487U108

10805129(+0.0%)

Value:

$19.9B(-26.1%)

GLAUKOS Corp

GKOS|377322102

190256

Value:

$18.7B

Monopar Therapeutics

MNPR|61023L207

511207(+0.0%)

Value:

$18.6B(+65.5%)

59267L107

675525

Value:

$18.4B

EyePoint Pharmaceuticals, Inc.

EYPT|30233G209

3181818(+0.0%)

Value:

$17.2B(-27.2%)

10x Genomics, Inc.

TXG|88025U109

1944247(-40.7%)

Value:

$17.0B(-64.0%)

Acrivon Therapeutics, Inc.

ACRV|004890109

8340508(+0.0%)

Value:

$16.9B(-66.3%)

Enliven Therapeutics, Inc.

ELVN|29337E102

848986(+0.0%)

Value:

$16.7B(-12.5%)

Acumen Pharmaceuticals, Inc.

ABOS|00509G209

14932063(+0.0%)

Value:

$16.4B(-36.0%)

Solid Biosciences Inc.

SLDB|83422E204

4330446(+0.0%)

Value:

$16.0B(-7.5%)

Ceribell, Inc.

CBLL|15678C102

824582(+0.0%)

Value:

$15.8B(-25.8%)

Nurix Therapeutics, Inc.

NRIX|67080M103

1333333(+0.0%)

Value:

$15.8B(-36.9%)

INSMED Inc

INSM|457669307

200000(+0.0%)

Value:

$15.3B(+10.5%)

Taysha Gene Therapies, Inc.

TSHA|877619106

10872503(+0.0%)

Value:

$15.1B(-19.6%)

PepGen Inc.

PEPG|713317105

10689545(+0.0%)

Value:

$15.0B(-62.9%)

4D Molecular Therapeutics, Inc.

FDMT|35104E100

4563211(+0.0%)

Value:

$14.7B(-42.0%)

Protara Therapeutics, Inc.

TARA|74365U107

3400000(+0.0%)

Value:

$14.5B(-19.3%)

Larimar Therapeutics, Inc.

LRMR|517125100

6045351(+0.0%)

Value:

$13.0B(-44.4%)

Eledon Pharmaceuticals, Inc.

ELDN|28617K101

3566338(+0.0%)

Value:

$12.1B(-17.7%)

Alector, Inc.

ALEC|014442107

9695228(+0.0%)

Value:

$11.9B(-34.9%)

Instrument	Shares		Other Manager	Value
Nkarta, Inc.(NKTXcusip65487U108)	10.8M	QoQ 0.00% (-0) YoY NEW(+10.8M)	All Managers (Combined)	$19.9M	QoQ -26.10% (-$7.0M) YoY NEW(+$19.9M)
Glaukos Corp(GKOScusip377322102)	190.3K	QoQ NEW(+190.3K) YoY NEW(+190.3K)	All Managers (Combined)	$18.7M	QoQ NEW(+$18.7M) YoY NEW(+$18.7M)
Monopar Therapeutics(MNPRcusip61023L207)	511.2K	QoQ 0.00% (+0) YoY NEW(+511.2K)	All Managers (Combined)	$18.6M	QoQ +65.50% (+$7.4M) YoY NEW(+$18.6M)
(cusip59267L107)✕	675.5K	QoQ NEW(+675.5K) YoY NEW(+675.5K)	All Managers (Combined)	$18.4M	QoQ NEW(+$18.4M) YoY NEW(+$18.4M)
Eyepoint Pharmaceuticals, Inc.(EYPTcusip30233G209)	3.2M	QoQ 0.00% (-0) YoY NEW(+3.2M)	All Managers (Combined)	$17.2M	QoQ -27.24% (-$6.5M) YoY NEW(+$17.2M)
10x Genomics, Inc.(TXGcusip88025U109)	1.9M	QoQ -40.71% (-1.3M) YoY NEW(+1.9M)	All Managers (Combined)	$17.0M	QoQ -63.95% (-$30.1M) YoY NEW(+$17.0M)
Acrivon Therapeutics, Inc.(ACRVcusip004890109)	8.3M	QoQ 0.00% (-0) YoY NEW(+8.3M)	All Managers (Combined)	$16.9M	QoQ -66.27% (-$33.3M) YoY NEW(+$16.9M)
Enliven Therapeutics, Inc.(ELVNcusip29337E102)	849.0K	QoQ 0.00% (-0) YoY NEW(+849.0K)	All Managers (Combined)	$16.7M	QoQ -12.53% (-$2.4M) YoY NEW(+$16.7M)
Acumen Pharmaceuticals, Inc.(ABOScusip00509G209)	14.9M	QoQ 0.00% (-0) YoY NEW(+14.9M)	All Managers (Combined)	$16.4M	QoQ -36.04% (-$9.3M) YoY NEW(+$16.4M)
Solid Biosciences Inc.(SLDBcusip83422E204)	4.3M	QoQ 0.00% (-0) YoY NEW(+4.3M)	All Managers (Combined)	$16.0M	QoQ -7.50% (-$1.3M) YoY NEW(+$16.0M)
Ceribell, Inc.(CBLLcusip15678C102)	824.6K	QoQ 0.00% (-0) YoY NEW(+824.6K)	All Managers (Combined)	$15.8M	QoQ -25.77% (-$5.5M) YoY NEW(+$15.8M)
Nurix Therapeutics, Inc.(NRIXcusip67080M103)	1.3M	QoQ 0.00% (-0) YoY NEW(+1.3M)	All Managers (Combined)	$15.8M	QoQ -36.94% (-$9.3M) YoY NEW(+$15.8M)
Insmed Inc(INSMcusip457669307)	200.0K	QoQ 0.00% (+0) YoY NEW(+200.0K)	All Managers (Combined)	$15.3M	QoQ +10.50% (+$1.4M) YoY NEW(+$15.3M)
Taysha Gene Therapies, Inc.(TSHAcusip877619106)	10.9M	QoQ 0.00% (-0) YoY NEW(+10.9M)	All Managers (Combined)	$15.1M	QoQ -19.65% (-$3.7M) YoY NEW(+$15.1M)
Pepgen Inc.(PEPGcusip713317105)	10.7M	QoQ 0.00% (-0) YoY NEW(+10.7M)	All Managers (Combined)	$15.0M	QoQ -62.92% (-$25.5M) YoY NEW(+$15.0M)
4d Molecular Therapeutics, Inc.(FDMTcusip35104E100)	4.6M	QoQ 0.00% (-0) YoY NEW(+4.6M)	All Managers (Combined)	$14.7M	QoQ -42.01% (-$10.7M) YoY NEW(+$14.7M)
Protara Therapeutics, Inc.(TARAcusip74365U107)	3.4M	QoQ 0.00% (-0) YoY NEW(+3.4M)	All Managers (Combined)	$14.5M	QoQ -19.31% (-$3.5M) YoY NEW(+$14.5M)
Larimar Therapeutics, Inc.(LRMRcusip517125100)	6.0M	QoQ 0.00% (-0) YoY NEW(+6.0M)	All Managers (Combined)	$13.0M	QoQ -44.44% (-$10.4M) YoY NEW(+$13.0M)
Eledon Pharmaceuticals, Inc.(ELDNcusip28617K101)	3.6M	QoQ 0.00% (-0) YoY NEW(+3.6M)	All Managers (Combined)	$12.1M	QoQ -17.71% (-$2.6M) YoY NEW(+$12.1M)
Alector, Inc.(ALECcusip014442107)	9.7M	QoQ 0.00% (-0) YoY NEW(+9.7M)	All Managers (Combined)	$11.9M	QoQ -34.92% (-$6.4M) YoY NEW(+$11.9M)